4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-059267
Chief Medical Officer sold 17,500 shares at $18.07 ($316,157)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2018-11-15 | Sale | −17,500 | $18.07 | $316,157 | 165,890 | I |
| Open-market sales · 17,500 sh · avg $18.07 · $316,157 | |||||||
Loading xslF345X03/doc4.xml…